NSCLC STAGE III
Clinical trials for NSCLC STAGE III explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE III trials appear
Sign up with your email to follow new studies for NSCLC STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for elderly lung cancer patients: chemo-free combo shows promise
Disease control CompletedThis study tested a combination of targeted radiation and an immunotherapy drug (durvalumab) in 51 elderly or frail patients with stage III lung cancer who could not tolerate chemotherapy. The goal was to see if this approach is safe and can shrink tumors. Results focused on side…
Matched conditions: NSCLC STAGE III
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated May 26, 2026 11:29 UTC
-
New drug duo shows promise against tough lung cancer
Disease control CompletedThis study tested whether adding two drugs, GFH018 and toripalimab, to standard chemoradiation helps people with stage III non-small cell lung cancer that cannot be removed by surgery. The trial included 65 adults who had not been treated before. The main goal was to see how many…
Matched conditions: NSCLC STAGE III
Phase: PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC